Hollings Home  
 
Charles L Bennett, MD, PhD
Professor of Clinical Pharmacy & Outcome Sciences
College of Pharmacy
USC

Email: bennettc@sccp.sc.edu
 
       Print This Page
       
 
 


 

Charles L Bennett, MD, PhD

Return to Search Page  

Research Interest:

My research interests include the identification and dissemination of information on adverse drug reactions; costs and quality of cancer care; health policy and minority issues for cancer patients; low literacy; and cancer prevention, screening, detection, and treatment. I am the principal investigator for the independent pharmaceutical safety program, the Research on Adverse Drug Events and Reports (RADAR) project, a National Institute of Health funded program that evaluates the safety of pharmaceuticals and medical devices with annual sales of $1 billion or greater. In the past decade, RADAR has identified 38 potentially fatal and previously unrecognized adverse drug reactions. The result has been improved safety information on product labels and savings of thousands of lives. All of the identified drugs or devices continue to have robust sales, but at the same time, their safety profiles have been improved.

Honors:
Endowed Chair in Medication Safety and Efficacy, SmartState Center of Economic Excellence

Selected Publications:

1.Bennett CL, Hermanson T. Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection-What Do We Know, and What More Do We Need to Know? Clin J Am Soc Nephrol. .10(10):1714-5, 2015. PMCID: PMC4594072
View in: PubMed

2.Bennett CL, Hermanson T. Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection-What Do We Know, and What More Do We Need to Know? Clin J Am Soc Nephrol. .10(10):1714-5, 2015. PMCID: PMC4594072
View in: PubMed

3.Hermanson TT, Hrushesky WJ, Knopf KB, Bennett CL. Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. .11(5):363-4, 2015.
View in: PubMed

4.Hermanson TT, Hrushesky WJ, Knopf KB, Bennett CL. Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. .11(5):363-4, 2015.
View in: PubMed

5.Prasad S, Hermanson T, Bennett CL, Sartor AO. Editorial Comment. Urology. .86(1):78, 2015.
View in: PubMed

6.Prasad S, Hermanson T, Bennett CL, Sartor AO. Editorial Comment. Urology. .86(1):78, 2015.
View in: PubMed

7.Isonishi A, Bennett CL, Plaimauer B, Scheiflinger F, Matsumoto M, Fujimura Y. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. .55(10):2321-30, 2015.
View in: PubMed

8.Mahal BA, Chen MH, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV, Nguyen PL. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. .26(7):1390-5, 2015. PMCID: PMC4478973
View in: PubMed

9.Prasad SM, Sartor AO, Bennett CL. Population-Based Assessment of Determining Treatments for Prostate Cancer. JAMA Oncol. .1(1):67-8, 2015.
View in: PubMed

10.Bennett CL, Chen B, Hermanson T, Georgantopoulos P, Sartor OA. Japanese regulatory authority's perspective on biosimilars - authors' reply. Lancet Oncol. .16(3):e102, 2015.
View in: PubMed

11.Bennett CL, Chen B, Hermanson T, Georgantopoulos P, Sartor OA. Japanese regulatory authority's perspective on biosimilars - authors' reply. Lancet Oncol. .16(3):e102, 2015.
View in: PubMed

12.Davis TC, Arnold CL, Bennett CL, Wolf MS, Liu D, Rademaker A. Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). .24(4):291-8, 2015. PMCID: PMC4394885
View in: PubMed

13.Davis TC, Arnold CL, Bennett CL, Wolf MS, Liu D, Rademaker A. Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). .24(4):291-8, 2015. PMCID: PMC4394885
View in: PubMed

14.Yada N, Fujioka M, Bennett CL, Inoki K, Miki T, Watanabe A, Yoshida T, Hayakawa M, Matsumoto M, Fujimura Y. STEC:O111-HUS complicated by acute encephalopathy in a young girl was successfully treated with a set of hemodiafiltration, steroid pulse, and soluble thrombomodulin under plasma exchange. Clin Case Rep. .3(4):208-12, 2015. PMCID: PMC4405303
View in: PubMed

15.Hermanson T, Sartor O, Ablin R, Bennett CL. Editorial comment. Urology. .85(2):413, 2015.
View in: PubMed

16.Hermanson T, Sartor O, Ablin R, Bennett CL. Editorial comment. Urology. .85(2):413, 2015.
View in: PubMed

17.Sartor O, Pal SK, Hermanson T, Bennett CL. Geography: an increasingly important variable in prostate cancer clinical trials. BJU Int. .115(1):2-3, 2015.
View in: PubMed

18.Sartor O, Pal SK, Hermanson T, Bennett CL. Geography: an increasingly important variable in prostate cancer clinical trials. BJU Int. .115(1):2-3, 2015.
View in: PubMed

19.Lu ZK, Yuan J, Li M, Sutton SS, Rao GA, Jacob S, Bennett CL. Cardiac risks associated with antibiotics: azithromycin and levofloxacin. Expert Opin Drug Saf. .14(2):295-303, 2014. PMCID: PMC4404501
View in: PubMed

20.Bennett CL, Chen B, Hermanson T, Wyatt MD, Schulz RM, Georgantopoulos P, Kessler S, Raisch DW, Qureshi ZP, Lu ZK, Love BL, Noxon V, Bobolts L, Armitage M, Bian J, Ray P, Ablin RJ, Hrushesky WJ, Macdougall IC, Sartor O, Armitage JO. Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. .15(13):e594-605, 2014. PMCID: PMC4404762
View in: PubMed

21.Hermanson T, Sartor O, Ablin RJ, Bennett CL. Editorial comment. Urology. .84(5):1072, 2014.
View in: PubMed

22.Hermanson T, Sartor O, Ablin RJ, Bennett CL. Editorial comment. Urology. .84(5):1072, 2014.
View in: PubMed

23.Sartor O, Bennett CL. Editorial comment. Urology. .85(1):153-4, 2014.
View in: PubMed

24.Sartor O, Bennett CL. Editorial comment. Urology. .85(1):153-4, 2014.
View in: PubMed

25.Hermanson T, Norris LB, Bian J, Sartor O, Bennett CL. Toxicity and costs of toxicity associated with new cancer drugs: international implications. J Clin Oncol. .32(32):3591-2, 2014.
View in: PubMed

26.Hermanson T, Norris LB, Bian J, Sartor O, Bennett CL. Toxicity and costs of toxicity associated with new cancer drugs: international implications. J Clin Oncol. .32(32):3591-2, 2014.
View in: PubMed

27.Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. .32(30):3436-48, 2014.
View in: PubMed

28.Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. .32(30):3436-48, 2014.
View in: PubMed

29.Bennett CL, Newsome SD, Sartor O, Carson KR. Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab. Cancer. .120(24):4006-7, 2014. PMCID: PMC4440419
View in: PubMed

30.Bennett CL, Newsome SD, Sartor O, Carson KR. Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab. Cancer. .120(24):4006-7, 2014. PMCID: PMC4440419
View in: PubMed

31.Bennett CL, Bian J. Erythropoiesis-stimulating agents and quality of life: personal journeys of a cancer survivor, oncologist, and two cancer health services researchers. Br J Cancer. .111(3):421-3, 2014. PMCID: PMC4119972
View in: PubMed

32.Bennett CL, Jacob S, Hymes J, Usvyat LA, Maddux FW. Anaphylaxis and hypotension after administration of peginesatide. N Engl J Med. .370(21):2055-6, 2014. PMCID: PMC4200528
View in: PubMed

33.Bennett CL, Jacob S, Hymes J, Usvyat LA, Maddux FW. Anaphylaxis and hypotension after administration of peginesatide. N Engl J Med. .370(21):2055-6, 2014. PMCID: PMC4200528
View in: PubMed

34.Kumthekar P, Stell BV, Jacobs DI, Helenowski IB, Rademaker AW, Grimm SA, Bennett CL, Raizer JJ. Financial burden experienced by patients undergoing treatment for malignant gliomas. Neurooncol Pract. .1(2):71-76, 2014. PMCID: PMC4371162
View in: PubMed

35.Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. .120(16):2464-71, 2014. PMCID: PMC4460831
View in: PubMed

36.Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. .120(16):2464-71, 2014. PMCID: PMC4460831
View in: PubMed

37.Prasad SM, Sartor O, Bennett CL. Editorial comment. Urology. .83(4):786-7, 2014.
View in: PubMed

38.Prasad SM, Sartor O, Bennett CL. Editorial comment. Urology. .83(4):786-7, 2014.
View in: PubMed

39.Rao GA, Mann JR, Shoaibi A, Bennett CL, Nahhas G, Sutton SS, Jacob S, Strayer SM. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. .12(2):121-7, 2014. PMCID: PMC3948758
View in: PubMed

40.Maxwell WD, Jacob M, Spiryda LB, Bennett CL. Selection of contraceptive therapy for patients with thrombophilia: a review of the evidence. J Womens Health (Larchmt). .23(4):318-26, 2014.
View in: PubMed

41.Prasad SM, Sartor O, Bennett CL. Reply to W. Read. J Clin Oncol. .32(6):604-5, 2014.
View in: PubMed

42.Prasad SM, Sartor O, Bennett CL. Reply to W. Read. J Clin Oncol. .32(6):604-5, 2014.
View in: PubMed

43.Davis TC, Rademaker A, Bennett CL, Wolf MS, Carias E, Reynolds C, Liu D, Arnold CL. Improving mammography screening among the medically underserved. J Gen Intern Med. .29(4):628-35, 2013. PMCID: PMC3965756
View in: PubMed

44.Davis TC, Rademaker A, Bennett CL, Wolf MS, Carias E, Reynolds C, Liu D, Arnold CL. Improving mammography screening among the medically underserved. J Gen Intern Med. .29(4):628-35, 2013. PMCID: PMC3965756
View in: PubMed

45.Hamed S, Bennett CL, Demiot C, Ullmann Y, Teot L, Desmoulière A. Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen. .22(1):23-33, 2013.
View in: PubMed

46.Hamed S, Bennett CL, Demiot C, Ullmann Y, Teot L, Desmoulière A. Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen. .22(1):23-33, 2013.
View in: PubMed

47.Prasad SM, Sartor AO, Bennett CL. Editorial comment. Urology. .83(1):152-3; discussion 153, 2013.
View in: PubMed

48.Davis TC, Arnold CL, Bennett CL, Wolf MS, Reynolds C, Liu D, Rademaker A. Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. .23(1):134-43, 2013. PMCID: PMC3894742
View in: PubMed

49.Davis TC, Arnold CL, Bennett CL, Wolf MS, Reynolds C, Liu D, Rademaker A. Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. .23(1):134-43, 2013. PMCID: PMC3894742
View in: PubMed

50.Magwood JS, Lebby A, Chen B, Kessler S, Norris L, Bennett CL. Emerging drugs for treatment of anemia of chronic kidney disease. Expert Opin Emerg Drugs. .18(4):421-9, 2013.
View in: PubMed

51.Kessler SJ, Bennett CL. Forewarned is forearmed: erythropoietin use in CKD patients with cancer. J Nephrol. .26(5):805-6, 2013.
View in: PubMed

52.Kessler SJ, Bennett CL. Forewarned is forearmed: erythropoietin use in CKD patients with cancer. J Nephrol. .26(5):805-6, 2013.
View in: PubMed

53.Rao GA, Mann JR, Shoaibi A, Pai SG, Bottai M, Sutton SS, Haddock KS, Bennett CL, Hebert JR. Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. .31(8):1669-75, 2013. PMCID: PMC3879726
View in: PubMed

54.Prasad SM, Bennett CL. Finishing the picture: problems with public reporting of clinical trials. J Clin Oncol. .31(24):2981-2, 2013.
View in: PubMed

55.Strassels SA, Dickson M, Norris LB, Bennett CL. Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis. J Natl Cancer Inst. .105(15):1072-3, 2013. PMCID: PMC3735465
View in: PubMed

56.Strassels SA, Dickson M, Norris LB, Bennett CL. Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis. J Natl Cancer Inst. .105(15):1072-3, 2013. PMCID: PMC3735465
View in: PubMed

57.Djulbegovic B, Norris LB, Bennett CL. Colony-stimulating factors for febrile neutropenia. N Engl J Med. .369(3):286, 2013.
View in: PubMed

58.Djulbegovic B, Norris LB, Bennett CL. Colony-stimulating factors for febrile neutropenia. N Engl J Med. .369(3):286, 2013.
View in: PubMed

59.Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP. The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. .112(5):548-60, 2013.
View in: PubMed

60.Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP. The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. .112(5):548-60, 2013.
View in: PubMed

61.Prasad SM, Bennett CL. Editorial comment. Urology. .82(1):66, 2013.
View in: PubMed

62.Rao GA, Mann JR, Bottai M, Uemura H, Burch JB, Bennett CL, Haddock KS, Hébert JR. Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. .53(7):773-8, 2013. PMCID: PMC3768141
View in: PubMed

63.Li YJ, Xirasagar S, Pumkam C, Krishnaswamy M, Bennett CL. Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol. .131(4):499-506, 2013.
View in: PubMed

64.Bennett CL, Jacob S, Dunn BL, Georgantopoulos P, Zheng XL, Kwaan HC, McKoy JM, Magwood JS, Qureshi ZP, Bandarenko N, Winters JL, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Ablin RJ, Rock G, Matsumoto M, Fujimura Y. Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol. .161(6):896-8, 2013. PMCID: PMC3804577
View in: PubMed

65.Bennett CL, Djulbegovic B, Norris LB, Armitage JO. Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med. .368(12):1131-9, 2013. PMCID: PMC3947590
View in: PubMed

66.Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB, Aaronson NK, Bennett CL, Herr HW, McGuire M, Shevrin D, McVary K, Cella D. Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. .32(1):26.e25-31, 2013.
View in: PubMed

67.Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB, Aaronson NK, Bennett CL, Herr HW, McGuire M, Shevrin D, McVary K, Cella D. Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. .32(1):26.e25-31, 2013.
View in: PubMed

68.Sutton SS, Stacy JJ, Mensch J, Torres-McGehee T, Bennett CL. Tackling community-acquired methicillin-resistant Staphylococcus aureus in collegiate football players following implementation of an anti-MRSA programme. Br J Sports Med. .48(4):284-5, 2013.
View in: PubMed

69.Prasad SM, Bennett CL. Editorial comment. Urology. .81(1):154; author reply 154, 2013.
View in: PubMed

70.Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. .81(1):130-4, 2013.
View in: PubMed

71.Cunningham JE, Walters CA, Hill EG, Ford ME, Barker-Elamin T, Bennett CL. Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program. Breast Cancer Res Treat. .137(2):589-98, 2012. PMCID: PMC3660400
View in: PubMed

72.Maxwell W, Bennett CL. Will newer anticoagulants improve therapy persistence? Arch Intern Med. .172(21):1689-90, 2012.
View in: PubMed

73.Kwaan HC, Bennett CL. Adverse effects of drugs on hemostasis and thrombosis. Semin Thromb Hemost. .38(8):755-8, 2012.
View in: PubMed

74.Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):845-53, 2012. PMCID: PMC3804561
View in: PubMed

75.Bennett CL, Spiegel DM, Macdougall IC, Norris L, Qureshi ZP, Sartor O, Lai SY, Tallman MS, Raisch DW, Smith SW, Silver S, Murday AS, Armitage JO, Goldsmith D. A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):783-96, 2012. PMCID: PMC3947540
View in: PubMed

76.Maxwell WD, Bennett CL. Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):759-67, 2012. PMCID: PMC4017864
View in: PubMed

77.Moore TJ, Bennett CL. Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):905-7, 2012. PMCID: PMC3947536
View in: PubMed

78.Bian J, Bennett CL, Fisher DA, Ribeiro M, Lipscomb J. Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol. .30(32):3947-52, 2012. PMCID: PMC3488268
View in: PubMed

79.Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL. A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract. .8(6):e158-67, 2012. PMCID: PMC3500490
View in: PubMed

80.Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL. A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract. .8(6):e158-67, 2012. PMCID: PMC3500490
View in: PubMed

81.Kyriacou DN, Dobrez D, Parada JP, Steinberg JM, Kahn A, Bennett CL, Schmitt BP. Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity. Biosecur Bioterror. .10(3):264-79, 2012. PMCID: PMC3440066
View in: PubMed

82.Prasad SM, Keane T, Bennett CL. Editorial comment. Urology. .80(3):563, 2012.
View in: PubMed

83.Bennett CL, Starko KM, Thomsen HS, Cowper S, Sartor O, Macdougall IC, Qureshi ZP, Bookstaver PB, Miller AD, Norris LB, Xirasagar S, Trenery A, Lopez I, Kahn A, Murday A, Luminari S, Cournoyer D, Locatelli F, Ray P, Mattison DR. Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med. .27(12):1697-703, 2012. PMCID: PMC3509314
View in: PubMed

84.Prasad SM, Keane TE, Bennett CL. Editorial comment. Urology. .80(1):168, 2012.
View in: PubMed

85.Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, West DP, Edwards BJ, Belknap SM, Liebling DB, Fisher MJ, Samaras AT, Jones LG, Tulas KM, McKoy JM. Amiodarone-associated optic neuropathy: a critical review. Am J Med. .125(5):447-53, 2012. PMCID: PMC3322295
View in: PubMed

86.Bennett CL. A 56-year-old physician who underwent a PSA test. Arch Intern Med. .172(4):311, 2012.
View in: PubMed

87.Bennett CL, Qureshi ZP, Sartor AO, Norris LB, Murday A, Xirasagar S, Thomsen HS. Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J. .5(1):82-88, 2012. PMCID: PMC3341839
View in: PubMed

88.Qureshi ZP, Norris L, Sartor O, McKoy JM, Armstrong J, Raisch DW, Garg V, Stafkey-Mailey D, Bennett CL. Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States. J Oncol Pract. .8(2):84-90, 2011. PMCID: PMC3457834
View in: PubMed

89.Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. .110(2):201-5, 2011.
View in: PubMed

90.Bennett CL. Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med. .78 Suppl 2:S13-7, 2011.
View in: PubMed

91.Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL. Pharmaceutical fraud and abuse in the United States, 1996-2010. Arch Intern Med. .171(16):1503-6, 2011.
View in: PubMed

92.Felder TM, Lal LS, Bennett CL, Hung F, Franzini L. Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center. Community Oncol. .8(6):279-286, 2011. PMCID: PMC3413301
View in: PubMed

93.Raisch DW, Campbell W, Garg V, Qureshi ZP, Bookstaver PB, Norris LB, Bennett CL. Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. Expert Opin Drug Saf. .10(4):521-8, 2011.
View in: PubMed

94.Qureshi ZP, Liu Y, Sartor O, Chu YH, Bennett CL. Enforcement actions involving Medicaid fraud and abuse, 1996-2009. Arch Intern Med. .171(8):785-7, 2011.
View in: PubMed

95.Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. .31(4):408-23, 2011.
View in: PubMed

96.Edwards BJ, Raisch DW, Shankaran V, McKoy JM, Gradishar W, Bunta AD, Samaras AT, Boyle SN, Bennett CL, West DP, Guise TA. Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clin Cancer Res. .17(3):560-8, 2011. PMCID: PMC3058419
View in: PubMed

97.Mortimer JE, Barsevick AM, Bennett CL, Berger AM, Cleeland C, DeVader SR, Escalante C, Gilreath J, Hurria A, Mendoza TR, Rugo HS. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. .8(12):1331-9, 2010.
View in: PubMed

98.Xirasagar S, Bennett CL, Hebert JR. Screening colonoscopy vs flexible sigmoidoscopy. JAMA. .304(18):2016-7; author reply 2017-8, 2010.
View in: PubMed

99.Miller AD, Piro CC, Rudisill CN, Bookstaver PB, Bair JD, Bennett CL. Nighttime and weekend medication error rates in an inpatient pediatric population. Ann Pharmacother. .44(11):1739-46, 2010.
View in: PubMed

100.Bennett CL, Lai SY, Henke M, Barnato SE, Armitage JO, Sartor O. Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents. Arch Intern Med. .170(16):1490-8, 2010. PMCID: PMC4138541
View in: PubMed

101.Ablin RJ, Sartor O, Bennett CL. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer". Arch Intern Med. .170(15):1397-9, 2010.
View in: PubMed

102.Mayhew R, McKoy JM, Ha Luu T, Lopez I, Frick M, Bennett CL. Adverse drug interactions: moving from perception to action. Pharmacoeconomics. .28(1):19-22, 2010.
View in: PubMed

103.Richey EA, Lyons EA, Nebeker JR, Shankaran V, McKoy JM, Luu TH, Nonzee N, Trifilio S, Sartor O, Benson AB, Carson KR, Edwards BJ, Gilchrist-Scott D, Kuzel TM, Raisch DW, Tallman MS, West DP, Hirschfeld S, Grillo-Lopez AJ, Bennett CL. Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol. .27(26):4398-405, 2009. PMCID: PMC2744277
View in: PubMed

104.Simon MA, Dong X, Bennett CL. Partnering to promote equality in cancer care. Soc Work Public Health. .24(4):355-9, 2009.
View in: PubMed

105.McKoy JM, Samaras AT, Luu TH, Bennett CL. Upping recruitment in clinical trials: are the costs worth it? Onkologie. .32(7):378-9, 2009.
View in: PubMed

106.McKoy JM, Samaras AT, Luu TH, Bennett CL. Upping recruitment in clinical trials: are the costs worth it? Onkologie. .32(7):378-9, 2009.
View in: PubMed

107.Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL. Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. .15(11):3850-5, 2009. PMCID: PMC3296235
View in: PubMed

108.Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL. Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. .15(11):3850-5, 2009. PMCID: PMC3296235
View in: PubMed

109.McKoy JM, Samaras AT, Bennett CL. Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? J Clin Oncol. .27(17):2745-6, 2009.
View in: PubMed

110.McKoy JM, Samaras AT, Bennett CL. Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? J Clin Oncol. .27(17):2745-6, 2009.
View in: PubMed

111.Simon MA, Dong X, Nonzee N, Bennett CL. Heeding our words: complexities of research among low-literacy populations. J Clin Oncol. .27(12):1938-40, 2009.
View in: PubMed

112.Simon MA, Dong X, Nonzee N, Bennett CL. Heeding our words: complexities of research among low-literacy populations. J Clin Oncol. .27(12):1938-40, 2009.
View in: PubMed

113.Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. .113(20):4834-40, 2009. PMCID: PMC2686134
View in: PubMed

114.Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. .113(20):4834-40, 2009. PMCID: PMC2686134
View in: PubMed

115.Carson KR, Bennett CL. Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leuk Lymphoma. .50(3):323-4, 2009.
View in: PubMed

116.Carson KR, Bennett CL. Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leuk Lymphoma. .50(3):323-4, 2009.
View in: PubMed

117.Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. .12(4):233-44, 2009. PMCID: PMC2844634
View in: PubMed

118.Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. .12(4):233-44, 2009. PMCID: PMC2844634
View in: PubMed

119.Pickard AS, Lin HW, Knight SJ, Knight SL, Sharifi R, Wu Z, Hung SY, Witt WP, Chang CH, Bennett CL. Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care. .47(2):176-83, 2009. PMCID: PMC3215256
View in: PubMed

120.Pickard AS, Lin HW, Knight SJ, Knight SL, Sharifi R, Wu Z, Hung SY, Witt WP, Chang CH, Bennett CL. Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care. .47(2):176-83, 2009. PMCID: PMC3215256
View in: PubMed

121.McKoy JM, Bolden CR, Samaras A, Raisch DW, Chandler K, Bennett CL. Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment. Community Oncol. .6(2):78-80, 2009. PMCID: PMC2800378
View in: PubMed

122.Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. .(112):S20-4, 2009. PMCID: PMC3500614
View in: PubMed

123.Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. .249(1):63-71, 2009.
View in: PubMed

124.McKoy JM, Bennett CL, Scheetz MH, Differding V, Chandler KL, Scarsi KK, Yarnold PR, Sutton S, Palella F, Johnson S, Obadina E, Raisch DW, Parada JP. Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Saf. .32(2):147-58, 2009. PMCID: PMC2768573
View in: PubMed

125.Bennett CL, Becker PS, Kraut EH, Samaras AT, West DP. Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer. Semin Dial. .22(1):1-4, 2008. PMCID: PMC3296236
View in: PubMed

126.Bennett CL, Becker PS, Kraut EH, Samaras AT, West DP. Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer. Semin Dial. .22(1):1-4, 2008. PMCID: PMC3296236
View in: PubMed

127.Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. .9(12):1166-72, 2008.
View in: PubMed

128.Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, Patel JD, Kern RC, Munshi HG, Calhoun EA, Bennett CL. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. .113(6):1446-52, 2008.
View in: PubMed

129.Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, Lee J, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB, Vedantham S. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. .6(8):716-53, 2008.
View in: PubMed

130.Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, Lee J, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB, Vedantham S. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. .6(8):716-53, 2008.
View in: PubMed

131.Rodgers GM, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. .6(6):536-64, 2008.
View in: PubMed

132.Rodgers GM, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. .6(6):536-64, 2008.
View in: PubMed

133.McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, Casadevall N, Bennett CL. Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. .48(8):1754-62, 2008. PMCID: PMC2730535
View in: PubMed

134.Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. .299(8):914-24, 2008.
View in: PubMed

135.McKoy JM, Tigue CC, Bennett CL. Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin. Cancer Treat Res. .140:235-51, 2008.
View in: PubMed

136.McKoy JM, Laumann A, Samaras A, Lacouture M, West D, Raisch D, Obadina E, Fajolu O, Reilly L, Bennett CL. Gadolinium-associated nephrogenic systemic fibrosis. Community Oncol. .5(6):325-326, 2008. PMCID: PMC2777717
View in: PubMed

137.Shankaran V, McKoy JM, Dandade N, Nonzee N, Tigue CA, Bennett CL, Denberg TD. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol. .25(33):5248-53, 2007.
View in: PubMed

138.Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood. .111(1):25-41, 2007.
View in: PubMed

139.Bennett CL, Kim B, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy JM, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, De Masi D, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. .50(12):1138-43, 2007. PMCID: PMC3167088
View in: PubMed

140.Djulbegovic B, Angelotta C, Knox KE, Bennett CL. The sound and the fury: financial conflicts of interest in oncology. J Clin Oncol. .25(24):3567-9, 2007.
View in: PubMed

141.Djulbegovic B, Angelotta C, Knox KE, Bennett CL. The sound and the fury: financial conflicts of interest in oncology. J Clin Oncol. .25(24):3567-9, 2007.
View in: PubMed

142.Courtney DM, Aldeen AZ, Gorman SM, Handler JA, Trifilio SM, Parada JP, Yarnold PR, Bennett CL. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. .12(8):1019-26, 2007.
View in: PubMed

143.Courtney DM, Aldeen AZ, Gorman SM, Handler JA, Trifilio SM, Parada JP, Yarnold PR, Bennett CL. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. .12(8):1019-26, 2007.
View in: PubMed

144.Angelotta C, McKoy JM, Fisher MJ, Buffie CG, Barfi K, Ramsey G, Frohlich L, Bennett CL. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia. Vox Sang. .93(2):159-65, 2007.
View in: PubMed

145.Fitzgibbon ML, Ferreira MR, Dolan NC, Davis TC, Rademaker AW, Wolf MS, Liu D, Gorby N, Schmitt BP, Bennett CL. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract. .8(3):273-81, 2007.
View in: PubMed

146.Fitzgibbon ML, Ferreira MR, Dolan NC, Davis TC, Rademaker AW, Wolf MS, Liu D, Gorby N, Schmitt BP, Bennett CL. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract. .8(3):273-81, 2007.
View in: PubMed

147.Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. .40(3):185-92, 2007.
View in: PubMed

148.McKoy JM, Fitzner KA, Edwards BJ, Alkhatib M, Tigue CC, Nonzee NJ, Bolden CR, Bennett CL. Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). .21(7):851-7; discussion 858, 860, 862 passim, 2007.
View in: PubMed

149.Bennett CL, Tigue CC, Angelotta C, McKoy JM, Edwards BJ. Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project. Semin Thromb Hemost. .33(4):365-72, 2007.
View in: PubMed

150.Bennett CL, Tigue CC, Angelotta C, McKoy JM, Edwards BJ. Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project. Semin Thromb Hemost. .33(4):365-72, 2007.
View in: PubMed

151.Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. .167(10):1041-9, 2007.
View in: PubMed

152.Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. .297(18):1992-2000, 2007.
View in: PubMed

153.Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI. G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. .137(6):545-52, 2007.
View in: PubMed

154.Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, Middleton R, Sharp SA, Smith TJ, Talcott J, Taplin M, Vogelzang NJ, Wade JL, Bennett CL, Scher HI. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. .25(12):1596-605, 2007.
View in: PubMed

155.Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, Middleton R, Sharp SA, Smith TJ, Talcott J, Taplin M, Vogelzang NJ, Wade JL, Bennett CL, Scher HI. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. .25(12):1596-605, 2007.
View in: PubMed

156.Bennett CL, Calhoun EA. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. .12(4):478-83, 2007.
View in: PubMed

157.Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. .99(3):196-205, 2007.
View in: PubMed

158.Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. .99(3):196-205, 2007.
View in: PubMed

159.Kyriacou DN, Yarnold PR, Stein AC, Schmitt BP, Soltysik RC, Nelson RR, Frerichs RR, Noskin GA, Belknap SM, Bennett CL. Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. .131(2):489-96, 2007.
View in: PubMed

160.Bennett CL, Tigue CC, Fitzner KA. The economics of brain metastases. Cancer Treat Res. .136:23-9, 2007.
View in: PubMed

161.Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, Zagory J, Trifilio S, Jakiche R, Palella F, Kahn A, Chandler K, Bennett CL. Systematic review of piperacillin-induced neutropenia. Drug Saf. .30(4):295-306, 2007.
View in: PubMed

162.Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, Zagory J, Trifilio S, Jakiche R, Palella F, Kahn A, Chandler K, Bennett CL. Systematic review of piperacillin-induced neutropenia. Drug Saf. .30(4):295-306, 2007.
View in: PubMed

163.Bennett CL, Angelotta C, Yarnold PR, Evens AM, Zonder JA, Raisch DW, Richardson P. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA. .296(21):2558-60, 2006.
View in: PubMed

164.Bennett CL, Angelotta C, Yarnold PR, Evens AM, Zonder JA, Raisch DW, Richardson P. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA. .296(21):2558-60, 2006.
View in: PubMed

165.Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. .65(2):253-60, 2006.
View in: PubMed

166.Bassuk AG, Chen YZ, Batish SD, Nagan N, Opal P, Chance PF, Bennett CL. In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome. Neurogenetics. .8(1):45-9, 2006.
View in: PubMed

167.Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. .135(5):642-50, 2006.
View in: PubMed

168.Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. .135(5):642-50, 2006.
View in: PubMed

169.Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB. Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. .4(9):838-69, 2006.
View in: PubMed

170.Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB. Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. .4(9):838-69, 2006.
View in: PubMed

171.McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM, Kuzel TM, Trifilio SM, Raisch DW, Kell J, DeAngelo DJ, Giles FJ. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res. .31(5):599-604, 2006.
View in: PubMed

172.Davis TC, Wolf MS, Bass PF, Middlebrooks M, Kennen E, Baker DW, Bennett CL, Durazo-Arvizu R, Bocchini A, Savory S, Parker RM. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. .21(8):847-51, 2006. PMCID: PMC1831578
View in: PubMed

173.Davis TC, Wolf MS, Bass PF, Middlebrooks M, Kennen E, Baker DW, Bennett CL, Durazo-Arvizu R, Bocchini A, Savory S, Parker RM. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. .21(8):847-51, 2006. PMCID: PMC1831578
View in: PubMed

174.Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard SA, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. .68(1):89-93, 2006.
View in: PubMed

175.Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst. .98(10):708-14, 2006.
View in: PubMed

176.Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst. .98(10):708-14, 2006.
View in: PubMed

177.Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol. .24(19):3187-205, 2006.
View in: PubMed

178.Adams JR, Angelotta C, Bennett CL. When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective? J Clin Oncol. .24(19):2975-7, 2006.
View in: PubMed

179.Adams JR, Angelotta C, Bennett CL. When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective? J Clin Oncol. .24(19):2975-7, 2006.
View in: PubMed

180.Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol. .24(19):3187-205, 2006.
View in: PubMed

181.Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. .20(5):359-68, 2006.
View in: PubMed

182.Belknap SM, Kuzel TM, Yarnold PR, Slimack N, Lyons EA, Raisch DW, Bennett CL. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. Cancer. .106(9):2051-7, 2006.
View in: PubMed

183.Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. .20(5):359-68, 2006.
View in: PubMed

184.Bennett CL. Cosmology from start to finish. Nature. .440(7088):1126-31, 2006.
View in: PubMed

185.Bennett CL. Cosmology from start to finish. Nature. .440(7088):1126-31, 2006.
View in: PubMed

186.Wolf MS, Bennett CL. Local perspective of the impact of the HIPAA privacy rule on research. Cancer. .106(2):474-9, 2006.
View in: PubMed

187.Kwaan HC, Bennett CL. Thrombotic thrombocytopenic purpura-2005. Semin Thromb Hemost. .31(6):611-4, 2005.
View in: PubMed

188.Wolf MS, Fitzner KA, Powell EF, McCaffrey KR, Pickard AS, McKoy JM, Lindenberg J, Schumock GT, Carson KR, Ferreira MR, Dolan NC, Bennett CL. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol. .23(34):8877-83, 2005.
View in: PubMed

189.Nebeker JR, Bennett CL. Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid. Cancer. .104(11):2289-91, 2005.
View in: PubMed

190.McKoy JM, Lyons EA, Obadina E, Carson K, Pickard AS, Schellhammer P, McLeod D, Boyd CE, McWilliams N, Sartor O, Schumock GT, McCaffery K, Bennett CL. Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs. J Clin Oncol. .23(34):8894-905, 2005.
View in: PubMed

191.Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. .47(1):175-81, 2005.
View in: PubMed

192.McKoy JM, Lyons EA, Obadina E, Carson K, Pickard AS, Schellhammer P, McLeod D, Boyd CE, McWilliams N, Sartor O, Schumock GT, McCaffery K, Bennett CL. Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs. J Clin Oncol. .23(34):8894-905, 2005.
View in: PubMed

193.Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. .47(1):175-81, 2005.
View in: PubMed

194.Nebeker JR, Bennett CL. Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid. Cancer. .104(11):2289-91, 2005.
View in: PubMed

195.Wolf MS, Davis TC, Arozullah A, Penn R, Arnold C, Sugar M, Bennett CL. Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care. .17(7):863-73, 2005.
View in: PubMed

196.Djulbegovic B, Frohlich A, Bennett CL. Acting on imperfect evidence: How much regret are we ready to accept? J Clin Oncol. .23(28):6822-5, 2005.
View in: PubMed

197.Djulbegovic B, Frohlich A, Bennett CL. Acting on imperfect evidence: How much regret are we ready to accept? J Clin Oncol. .23(28):6822-5, 2005.
View in: PubMed

198.Wolf MS, Bennett CL, Davis TC, Marin E, Arnold C. A qualitative study of literacy and patient response to HIV medication adherence questionnaires. J Health Commun. .10(6):509-17, 2005.
View in: PubMed

199.Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood. .106(10):3343-7, 2005. PMCID: PMC1895064
View in: PubMed

200.Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood. .106(10):3343-7, 2005. PMCID: PMC1895064
View in: PubMed

201.Pickard AS, Hung SY, McKoy JM, Witt WP, Arseven A, Sharifi R, Wu Z, Knight SJ, McWilliams N, Schumock GT, Bennett CL. Opportunities for disease state management in prostate cancer. Dis Manag. .8(4):235-44, 2005.
View in: PubMed

202.Pickard AS, Hung SY, McKoy JM, Witt WP, Arseven A, Sharifi R, Wu Z, Knight SJ, McWilliams N, Schumock GT, Bennett CL. Opportunities for disease state management in prostate cancer. Dis Manag. .8(4):235-44, 2005.
View in: PubMed

203.Kramer KM, Bennett CL, Pickard AS, Lyons EA, Wolf MS, McKoy JM, Knight SJ. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer. .4(1):15-23, 2005.
View in: PubMed

204.Kramer KM, Bennett CL, Pickard AS, Lyons EA, Wolf MS, McKoy JM, Knight SJ. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer. .4(1):15-23, 2005.
View in: PubMed

205.Dolan NC, Ferreira MR, Fitzgibbon ML, Davis TC, Rademaker AW, Liu D, Lee J, Wolf M, Schmitt BP, Bennett CL. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. .28(5):479-82, 2005.
View in: PubMed

206.Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. .165(10):1111-6, 2005.
View in: PubMed

207.Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. .165(10):1111-6, 2005.
View in: PubMed

208.Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW. The Research on Adverse Drug Events and Reports (RADAR) project. JAMA. .293(17):2131-40, 2005.
View in: PubMed

209.Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW. The Research on Adverse Drug Events and Reports (RADAR) project. JAMA. .293(17):2131-40, 2005.
View in: PubMed

210.Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, Rusch VW. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. .79(5):1698-703, 2005.
View in: PubMed

211.Zakarija A, Bennett CL. Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations? Arch Intern Med. .165(7):722-3, 2005.
View in: PubMed

212.Zakarija A, Bennett CL. Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations? Arch Intern Med. .165(7):722-3, 2005.
View in: PubMed

213.Wolf MS, Rademaker A, Bennett CL, Ferreira MR, Dolan NC, Davis TC, Medio F, Liu D, Lee J, Fitzgibbon M. Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis. .2(2):A11, 2005. PMCID: PMC1327705
View in: PubMed

214.Ferreira MR, Dolan NC, Fitzgibbon ML, Davis TC, Gorby N, Ladewski L, Liu D, Rademaker AW, Medio F, Schmitt BP, Bennett CL. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol. .23(7):1548-54, 2005.
View in: PubMed

215.Ferreira MR, Dolan NC, Fitzgibbon ML, Davis TC, Gorby N, Ladewski L, Liu D, Rademaker AW, Medio F, Schmitt BP, Bennett CL. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol. .23(7):1548-54, 2005.
View in: PubMed

216.Bennett CL. Astrophysical observations: lensing and eclipsing Einstein's theories. Science. .307(5711):879-84, 2005.
View in: PubMed

217.Bennett CL. Astrophysical observations: lensing and eclipsing Einstein's theories. Science. .307(5711):879-84, 2005.
View in: PubMed

218.Rozovsky-Weinberger J, Parada JP, Phan L, Droller DG, Deloria-Knoll M, Chmiel JS, Bennett CL. Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999. Chest. .127(1):205-12, 2005.
View in: PubMed

219.Bohlius JF, Langensiepen S, Engert A, Schwarzer G, Bennett CL. Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review. Best Pract Res Clin Haematol. .18(3):449-54, 2005.
View in: PubMed

220.Rozovsky-Weinberger J, Parada JP, Phan L, Droller DG, Deloria-Knoll M, Chmiel JS, Bennett CL. Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999. Chest. .127(1):205-12, 2005.
View in: PubMed

221.Bohlius JF, Langensiepen S, Engert A, Schwarzer G, Bennett CL. Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review. Best Pract Res Clin Haematol. .18(3):449-54, 2005.
View in: PubMed

222.Calhoun EA, Schumock GT, McKoy JM, Pickard S, Fitzner KA, Heckinger EA, Powell EF, McCaffrey KR, Bennett CL. Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited. Pharmacoeconomics. .23(8):767-75, 2005.
View in: PubMed

223.Calhoun EA, Schumock GT, McKoy JM, Pickard S, Fitzner KA, Heckinger EA, Powell EF, McCaffrey KR, Bennett CL. Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited. Pharmacoeconomics. .23(8):767-75, 2005.
View in: PubMed

224.Evens AM, Bennett CL, Luminari S. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group. Best Pract Res Clin Haematol. .18(3):481-9, 2005.
View in: PubMed

225.Carson KR, Evens AM, Bennett CL, Luminari S. Clinical characteristics of erythropoietin-associated pure red cell aplasia. Best Pract Res Clin Haematol. .18(3):467-72, 2005.
View in: PubMed

226.Bennett CL. The blue cross blue shield assessment technology review: summary of findings. Best Pract Res Clin Haematol. .18(3):423-31, 2005.
View in: PubMed

227.Macpherson GR, Singh AS, Bennett CL, Venzon DJ, Liewehr DJ, Franks ME, Dahut WL, Kantoff PW, Price DK, Figg WD. Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. .3(12):1298-303, 2004.
View in: PubMed

228.Macpherson GR, Singh AS, Bennett CL, Venzon DJ, Liewehr DJ, Franks ME, Dahut WL, Kantoff PW, Price DK, Figg WD. Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. .3(12):1298-303, 2004.
View in: PubMed

229.Bennett CL, Calhoun EA. Pharmacoeconomics of liposomal anthracycline therapy. Semin Oncol. .31(6 Suppl 13):191-5, 2004.
View in: PubMed

230.Wolf MS, Davis TC, Cross JT, Marin E, Green K, Bennett CL. Health literacy and patient knowledge in a Southern US HIV clinic. Int J STD AIDS. .15(11):747-52, 2004.
View in: PubMed

231.Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N. Pure red-cell aplasia and epoetin therapy. N Engl J Med. .351(14):1403-8, 2004.
View in: PubMed

232.Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N. Pure red-cell aplasia and epoetin therapy. N Engl J Med. .351(14):1403-8, 2004.
View in: PubMed

233.Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, Bennett CL. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. .22(17):3524-30, 2004.
View in: PubMed

234.Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, Bennett CL. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. .22(17):3524-30, 2004.
View in: PubMed

235.Dolan NC, Ferreira MR, Davis TC, Fitzgibbon ML, Rademaker A, Liu D, Schmitt BP, Gorby N, Wolf M, Bennett CL. Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. .22(13):2617-22, 2004.
View in: PubMed

236.Golub RM, Bennett CL, Stinson T, Venta L, Morrow M. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. .22(12):2430-7, 2004.
View in: PubMed

237.Golub RM, Bennett CL, Stinson T, Venta L, Morrow M. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. .22(12):2430-7, 2004.
View in: PubMed

238.Loblaw DA, Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ, Taplin ME, Vogelzang NJ, Wade JL, Bennett CL, Scher HI. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol. .22(14):2927-41, 2004.
View in: PubMed

239.Loblaw DA, Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ, Taplin ME, Vogelzang NJ, Wade JL, Bennett CL, Scher HI. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol. .22(14):2927-41, 2004.
View in: PubMed

240.Knight SJ, Siston AK, Chmiel JS, Slimack N, Elstein AS, Chapman GB, Nadler RB, Bennett CL. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. .3(1):31-7, 2004.
View in: PubMed

241.Elstein AS, Chapman GB, Chmiel JS, Knight SJ, Chan C, Nadler RB, Kuzel TM, Siston AK, Bennett CL. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance. Health Expect. .7(2):115-25, 2004.
View in: PubMed

242.Knight SJ, Siston AK, Chmiel JS, Slimack N, Elstein AS, Chapman GB, Nadler RB, Bennett CL. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. .3(1):31-7, 2004.
View in: PubMed

243.Elstein AS, Chapman GB, Chmiel JS, Knight SJ, Chan C, Nadler RB, Kuzel TM, Siston AK, Bennett CL. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance. Health Expect. .7(2):115-25, 2004.
View in: PubMed

244.Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, Gorby NS, Schumock GT, Bennett CL. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. .2(3):271-8, 2004.
View in: PubMed

245.Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, Gorby NS, Schumock GT, Bennett CL. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. .2(3):271-8, 2004.
View in: PubMed

246.Calhoun EA, Fishman DA, Lurain JR, Welshman EE, Bennett CL. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecol Oncol. .93(1):164-9, 2004.
View in: PubMed

247.Sureka A, Parada JP, Deloria-Knoll M, Chmiel JS, Phan L, Lyons TM, Ali S, Yarnold PR, Weinstein RA, Dehovitz JA, Jacobson JM, Goetz MB, Campo RE, Berland D, Bennett CL, Uphold CR. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. .18(2):99-107, 2004.
View in: PubMed

248.Uphold CR, Deloria-Knoll M, Palella FJ, Parada JP, Chmiel JS, Phan L, Bennett CL. US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. .125(2):548-56, 2004.
View in: PubMed

249.Uphold CR, Deloria-Knoll M, Palella FJ, Parada JP, Chmiel JS, Phan L, Bennett CL. US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. .125(2):548-56, 2004.
View in: PubMed

250.Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, Kwaan HC, McKoy JM, Schmitt BP, Davidson CJ, Yarnold PR, Gorelick PB, Bennett CL. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. .35(2):533-7, 2004.
View in: PubMed

251.Kim SP, Feinglass J, Bennett CL, Lyons T, Simon C, Weinberg MN, Talamonti MS. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. .22(2):225-33, 2004.
View in: PubMed

252.Adams JR, Elting LS, Lyman GH, George JN, Lembersky BC, Armitage JO, Demetri GD, Bennett CL. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. .116(1):28-34, 2004.
View in: PubMed

253.Adams JR, Elting LS, Lyman GH, George JN, Lembersky BC, Armitage JO, Demetri GD, Bennett CL. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. .116(1):28-34, 2004.
View in: PubMed

254.Parada JP, Deloria-Knoll M, Chmiel JS, Arozullah AM, Phan L, Ali SN, Goetz MB, Weinstein RA, Campo R, Jacobson J, Dehovitz J, Berland D, Bennett CL. Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. .37(11):1549-55, 2003.
View in: PubMed

255.Parada JP, Deloria-Knoll M, Chmiel JS, Arozullah AM, Phan L, Ali SN, Goetz MB, Weinstein RA, Campo R, Jacobson J, Dehovitz J, Berland D, Bennett CL. Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. .37(11):1549-55, 2003.
View in: PubMed

256.Bennett CL. Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer. Crit Rev Oncol Hematol. .48(Suppl):S71-4, 2003.
View in: PubMed

257.Bennett CL. Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer. Crit Rev Oncol Hematol. .48(Suppl):S71-4, 2003.
View in: PubMed

258.Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol. .21(20):3859-66, 2003.
View in: PubMed

259.Talamonti MS, Kim SP, Yao KA, Wayne JD, Feinglass J, Bennett CL, Rao S. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. .134(4):720-7; discussion 727-9, 2003.
View in: PubMed

260.Arozullah AM, Parada J, Bennett CL, Deloria-Knoll M, Chmiel JS, Phan L, Yarnold PR. A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest. .123(4):1151-60, 2003.
View in: PubMed

261.Arozullah AM, Parada J, Bennett CL, Deloria-Knoll M, Chmiel JS, Phan L, Yarnold PR. A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest. .123(4):1151-60, 2003.
View in: PubMed

262.Bennett CL, Somerfield MR, Pfister DG, Tomori C, Yakren S, Bach PB. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol. .21(5):937-41, 2003.
View in: PubMed

263.Bennett CL, Somerfield MR, Pfister DG, Tomori C, Yakren S, Bach PB. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol. .21(5):937-41, 2003.
View in: PubMed

264.MacDonald LA, Meyers S, Bennett CL, Fintel D, Grosshans N, Syegco R, Davidson CJ. Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol. .15(2):60-2, 2003.
View in: PubMed

265.MacDonald LA, Meyers S, Bennett CL, Fintel D, Grosshans N, Syegco R, Davidson CJ. Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol. .15(2):60-2, 2003.
View in: PubMed

266.Bennett CL, Schumock GT. Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making? Drugs Aging. .20(7):479-83, 2003.
View in: PubMed

267.Bennett CL, Schumock GT. Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making? Drugs Aging. .20(7):479-83, 2003.
View in: PubMed

268.Calhoun EA, Bennett CL. Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program. Oncology (Williston Park). .17(1):109-14; discussion 119-21, 2003.
View in: PubMed

269.Siston AK, Knight SJ, Slimack NP, Chmiel JS, Nadler RB, Lyons TM, Kuzel TM, Moran EM, Sharifi R, Bennett CL. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. .61(1):172-8, 2003.
View in: PubMed

270.Bennett CL, Schumock GT, Desai AA, Kwaan HC, Raisch DW, Newlin R, Stadler W. Thalidomide-associated deep vein thrombosis and pulmonary embolism. Am J Med. .113(7):603-6, 2002.
View in: PubMed

271.Bennett CL, Schumock GT, Desai AA, Kwaan HC, Raisch DW, Newlin R, Stadler W. Thalidomide-associated deep vein thrombosis and pulmonary embolism. Am J Med. .113(7):603-6, 2002.
View in: PubMed

272.Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. .100(7):2303-20, 2002.
View in: PubMed

273.Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. .20(19):4083-107, 2002.
View in: PubMed

274.Bennett CL, Raisch DW, Sartor O. Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect. Ann Intern Med. .137(7):625, 2002.
View in: PubMed

275.Bennett CL, Raisch DW, Sartor O. Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect. Ann Intern Med. .137(7):625, 2002.
View in: PubMed

276.Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. .20(19):4083-107, 2002.
View in: PubMed

277.Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. .100(7):2303-20, 2002.
View in: PubMed

278.Evens AM, Kwaan HC, Kaufman DB, Bennett CL. TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology. Transplantation. .74(6):885-7, 2002.
View in: PubMed

279.Evens AM, Kwaan HC, Kaufman DB, Bennett CL. TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology. Transplantation. .74(6):885-7, 2002.
View in: PubMed

280.Clark O, Adams JR, Bennett CL, Djulbegovic B. Erythropoietin, uncertainty principle and cancer related anaemia. BMC Cancer. .2:23, 2002. PMCID: PMC130027
View in: PubMed

281.Clark O, Adams JR, Bennett CL, Djulbegovic B. Erythropoietin, uncertainty principle and cancer related anaemia. BMC Cancer. .2:23, 2002. PMCID: PMC130027
View in: PubMed

282.Adams JR, Lyman GH, Djubegovic B, Feinglass J, Bennett CL. G-CSF as prophylaxis of febrile neutropenia in SCLC. Expert Opin Pharmacother. .3(9):1273-81, 2002.
View in: PubMed

283.Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status. J Clin Oncol. .20(17):3599-604, 2002.
View in: PubMed

284.Knight SJ, Nathan DP, Siston AK, Kattan MW, Elstein AS, Collela KM, Wolf MS, Slimack NS, Bennett CL, Golub RM. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. .1(2):105-14, 2002.
View in: PubMed

285.Knight SJ, Nathan DP, Siston AK, Kattan MW, Elstein AS, Collela KM, Wolf MS, Slimack NS, Bennett CL, Golub RM. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. .1(2):105-14, 2002.
View in: PubMed

286.Adams JR, Lyman GH, Djubegovic B, Feinglass J, Bennett CL. G-CSF as prophylaxis of febrile neutropenia in SCLC. Expert Opin Pharmacother. .3(9):1273-81, 2002.
View in: PubMed

287.Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status. J Clin Oncol. .20(17):3599-604, 2002.
View in: PubMed

288.Johnson S, Chan J, Bennett CL. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med. .137(2):146-7, 2002.
View in: PubMed

289.Johnson S, Chan J, Bennett CL. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med. .137(2):146-7, 2002.
View in: PubMed

290.Samson DJ, Seidenfeld J, Schmitt B, Hasselblad V, Albertsen PC, Bennett CL, Wilt TJ, Aronson N. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. .95(2):361-76, 2002.
View in: PubMed

291.Samson DJ, Seidenfeld J, Schmitt B, Hasselblad V, Albertsen PC, Bennett CL, Wilt TJ, Aronson N. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. .95(2):361-76, 2002.
View in: PubMed

292.Golub R, Adams J, Dave S, Bennett CL. Cost-effectiveness considerations in the treatment of essential thrombocythemia. Semin Oncol. .29(3 Suppl 10):28-32, 2002.
View in: PubMed

293.Lindau ST, Tomori C, Lyons T, Langseth L, Bennett CL, Garcia P. The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol. .186(5):938-43, 2002.
View in: PubMed

294.Adams JR, Nathan DP, Bennett CL. Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy. Blood Rev. .16(1):65-7, 2002.
View in: PubMed

295.Weinberg PD, Hounshell J, Sherman LA, Godwin J, Ali S, Tomori C, Bennett CL. Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med. .136(4):312-9, 2002.
View in: PubMed

296.Kim B, Lyons TM, Parada JP, Uphold CR, Yarnold PR, Hounshell JB, Sipler AM, Goetz MB, DeHovitz JA, Weinstein RA, Campo RE, Bennett CL. HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med. .16(9):583-9, 2001. PMCID: PMC1495267
View in: PubMed

297.Calhoun EA, Chang CH, Welshman EE, Fishman DA, Lurain JR, Bennett CL. Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist. .6(5):441-5, 2001.
View in: PubMed

298.Bennett CL, Crane JM. Quality improvement efforts in oncology: are we ready to begin? Cancer Invest. .19(1):86-95, 2001.
View in: PubMed